• 2008
    • Meex, S. J., van Vliet-Ostaptchouk, J. V., van der Kallen, C. J. H., van Greevenbroek, M. M. J., Schalkwijk, C. G., Feskens, E. J. M., Blaak, E. E., Wijmenga, C., Hofker, M. H., Stehouwer, C. D., & de Bruin, T. W. (2008). Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: Association study in 2000 Dutch Caucasians. Molecular Genetics and Metabolism, 94(3), 352-355. https://doi.org/10.1016/j.ymgme.2008.03.011
  • 2007
    • Meex, S. J., van Greevenbroek, M. M. J., Ayoubi, T. A., Vlietinck, R., van Vliet-Ostaptchouk, J. V., Hofker, M. H., Vermeulen, V. M., Schalkwijk, C. G., Feskens, E. J., Boer, J. M., Stehouwer, C. D., van der Kallen, C. J. H., & de Bruin, T. W. (2007). Activating transcription factor 6 polymorphisms and haplotypes are associated with impaired glucose homeostasis and type 2 diabetes in Dutch Caucasians. Journal of Clinical Endocrinology & Metabolism, 92(7), 2720-2725. https://doi.org/10.1210/jc.2006-2280
    • op den Buijsch, R. A., van de Plas, A., Stolk, L. M. L., Christiaans, M. H., van Hooff, J. P., Undre, N. A., van Dieijen-Visser, M. P., & Bekers, O. (2007). Evaluation of limited sampling strategies for tacrolimus. European Journal of Clinical Pharmacology, 63(11), 1039-1044. https://doi.org/10.1007/s00228-007-0354-9
    • Veltkamp, M., Wijnen, P. A. H. M., Moorsel, C. H., Rijkers, G. T., Ruven, H. J., Heron, M., Bekers, O., Claessen, A. M., Drent, M., Van den Bosch, J. M. M., & Grutters, J. C. (2007). Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis.Clinical and Experimental Immunology, 149(3), 453-462. https://doi.org/10.1111/j.1365-2249.2007.03428.x
    • Wijnen, P. A. H. M., Op den Buisch, R., Drent, M., Kuipers, P. M. J. C., Neefs, C., Bast, A., Bekers, O., & Koek, G. H. (2007). Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.Alimentary Pharmacology & Therapeutics, 26(2), 211-219. https://doi.org/10.1111/j.1365-2036.2007.03490.x
    • op den Buijsch, R. A., Christiaans, M. H., Stolk, L. M. L., de Vries, J. E., Cheung, C. Y., Undre, N. A., van Hooff, J. P., van Dieijen-Visser, M. P., & Bekers, O. (2007). Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms. Fundamental & Clinical Pharmacology, 21(4), 427-435. https://doi.org/10.1111/j.1472-8206.2007.00504.x
    • Llerena, A., Michel, G., Jeannesson, E., Wong, S., Manolopoulos, V. G., Hockett, R. D., Boubekeur, K., Siest, G., Beaune, P., Haefliger, C., Arnold, H. P., Junien, C., Petrovic, N., Molloy, R., Bekers, O., Donnelly, C., Arens, H. J., Kaput, J., & McComb, J. (2007). Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?". Clinical Chemistry and Laboratory Medicine, 45(7), 843-850. https://doi.org/10.1515/CCLM.2007.182
  • 2005
    • Fischer, M. A. J. G., Gransier, T. J., Beckers, L. M., Bekers, O., Bast, A., & Haenen, G. R. (2005). Determination of the antioxidant capacity in blood. Clinical Chemistry and Laboratory Medicine, 43(7), 735-740. https://doi.org/10.1515/CCLM.2005.125
    • op den Buijsch, R. A., de Vries, J. E., Loots, W. J., Landt, O., Wijnen, P. A. H. M., van Dieijen-Visser, M. P., & Bekers, O. (2005). Genotyping of the PXR A11156C polymorphism with locked nucleic acid containing fluorogenic probes. Pharmacogenomics, 5(2), 72-74. https://doi.org/10.1038/sj.tpj.6500299
    • Slofstra, S. H., van 't Veer, C., Buurman, W. A., Reitsma, P. H., ten Cate, H., & Spek, C. A. (2005). Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Critical Care Medicine, 33(6), 1365-1370. https://doi.org/10.1097/01.CCM.0000166370.94927.B6
    • van der Meijden, P. E. J., Feijge, M. A. H., Giesen, P. L. A., Huijberts, M. S. P., van Raak, L. P., & Heemskerk, J. W. (2005). Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thrombosis and Haemostasis, 93(6), 1128-1136. https://doi.org/10.1160/TH04-09-0597
    • Beerenhout, C. H., Luik, A. J., Jeuken Mertens, S. G., Bekers, O., Menheere, P. P., Hover, L., Klaassen, L., van der Sande, F. M., Cheriex, E. C., Meert, N., Leunissen, K. M. L., & Kooman, J. P. (2005). Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. Nephrology Dialysis Transplantation, 20(6), 1155-1163. https://doi.org/10.1093/ndt/gfh775
    • op den Buijsch, R. A., Wijnen, P. A. H. M., van Dieijen-Visser, M. P., de Vries, J. E., & Bekers, O. (2005). Rapid genotyping of the OATP1B1 polymorphisms A388G and T521C with real-time PCR FRET assays. Pharmacogenomics, 6(4), 393-397. https://doi.org/10.1517/14622416.6.4.393
    • Meex, S. J. R., van der Kallen, C. J. H., van Greevenbroek, M. M., Eurlings, P. M., El Hasnaoui, M. M., Evelo, C. T., Lindsey, P. J., Luiken, J. J. F. P., Glatz, J. F., & de Bruin, T. W. (2005). Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia. Faseb Journal, 19(14), 2063-2065. https://doi.org/10.1096/fj.04-2403fje
  • 2004
    • Keuren, J. F. W., Wielders, S. J. H., Driessen, A., Verhoeven, M., Hendriks, M., & Lindhout, T. (2004). Covalently-bound heparin makes collagen thromboresistant.Arteriosclerosis Thrombosis and Vascular Biology, 24(3), 613-617. https://doi.org/10.1161/01.ATV.0000116026.18945.66
    • Beerenhout, C., Noris, M., Kooman, J. P., Porrati, F., Binda, E., Morigi, M., Bekers, O., van der Sande, F. M., Todeschini, M., Macconi, D., Leunissen, K. M. L., & Remuzzi, F. R. C. P. (2004). Nitric oxide synthetic capacity in relation to dialysate temperature. Blood Purification, 22(2), 203-209. https://doi.org/10.1159/000076854
    • van Boxtel, M. P. J., Menheere, P. P. C. A., Bekers, O., Hogervorst, E., & Jolles, J. (2004). Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology, 29(7), 891-898. https://doi.org/10.1016/j.psyneuen.2003.08.002
  • 2003
    • Rothkrantz-Kos, S., Bekers, O., Gubbels, A., Drent, M., Schmitz, M. P., & van Dieijen-Visser, M. P. (2003). Evaluation of two new high-sensitivity methods for C-reactive protein. Annals of Clinical Biochemistry, 40(Pt 4), 398-405. https://doi.org/10.1258/000456303766477057
    • Briedé, J. J., Wielders, S. J. H., Heemskerk, J. W. M., Baruch, D., Hemker, H. C., & Lindhout, T. (2003). von Willebrand factor stimulates thrombin-induced exposure of procoagulant phospholipids on the surface of fibrin-adherent platelets. Thrombosis and Haemostasis, 1(3), 559-565. https://doi.org/10.1046/j.1538-7836.2003.00077.x
  • 2002
    • Rothkrantz-Kos, S., Schmitz, M. P. J., Bekers, O., Menheere, P. P. C. A., & van Dieijen-Visser, M. P. (2002). High-sensitivity C-reactive protein methods examined. Clinical Chemistry, 48(2), 359-362. https://doi.org/10.1093/CLINCHEM/48.2.359
  • 1999
    • Curvers, J., Christella, M., Thomassen, L. G. D., Nicolaes, G. A. F., van Oerle, R., Hamulyak, K., Hemker, H. C., Tans, G., & Rosing, J. (1999). Acquired APC resistance and oral contraceptives: Differences between two functional tests. British Journal of Haematology, 105(1), 88-94. https://doi.org/10.1111/j.1365-2141.1999.01302.x
  • 1997
    • Wielders, S., Mukherjee, M., Michiels, J., Rijkers, D. T. S., Cambus, J.-P., Knebel, R. W. C., Kakkar, V., Hemker, H. C., & Beguin, S. (1997). The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thrombosis and Haemostasis, 77(4), 629-636. https://doi.org/10.1055/s-0038-1656024
    • Rosing, J., Tans, G., Nicolaes, G. A. F., Thomassen, M. C. G. L. D., van Oerle, R., van der Ploeg, P. M. E. N., Heijnen, P., Hamulyak, K., & Hemker, H. C. (1997). Oral contraceptives and venous thrombosis: Different sensitives to activated protein C in women using second-and third-generation oral contraceptives. British Journal of Haematology, 97(1), 233-238. https://doi.org/10.1046/j.1365-2141.1997.192707.x
  • 1996
    • Nicolaes, G. A. F., Thomassen, M. C. L. G. D., van Oerle, R., Hamulyak, K., Hemker, H. C., Tans, G., & Rosing, J. (1996). A prothrombinase-based assay for detection of resistance to activated protein C. Thrombosis and Haemostasis, 76(3), 404-410. https://doi.org/10.1055/s-0038-1650591
  • 1993
    • Hemker, H. C., Wielders, S., Kessels, H., & Beguin, S. (1993). Continuous registration of thrombin generation in plasma: Its use for the determination of the thrombin potential. Thrombosis and Haemostasis, 70(4), 617-624. https://doi.org/10.1055/s-0038-1649638
  • 1992
    • Beguin, S., Wielders, S., Lormeau, J. C., & Hemker, H. C. (1992). The Mode of Action of CY216 and CY222 in Plasma. Thrombosis and Haemostasis, 67(1), 33-41. https://doi.org/10.1055/s-0038-1648375
  • 1991
    • Hemker, H. C., Beguin, S., Bendetowicz, A. V., & Wielders, S. (1991). Determination of the levels of unfractionated and low-molecular-weight heparins in plasma: Their effect on thrombin-mediated feedback reactions in vivo. Haemostasis, 21(4), 258-272. https://doi.org/10.1159/000216235
    • Yukelson, L. Y., Tans, G., Thomassen, M. C. L. G. D., Hemker, H. C., & Rosing, J. (1991). Procoagulant activities in venoms from Central Asian snakes. Toxicon, 29(4-5), 491-502. https://doi.org/10.1016/0041-0101(91)90023-K